Skip to content

MO ACTIVITIES

Active
Private limited company·Activiteiten van medisch specialisten· 5 yrs active
Papenkasteelstraat 33 ·1180 Ukkel, Belgium
KBO/BCE: BE 0770.711.322
Watch Print / PDF
Age5 yrs
Board3
Staff (FTE)7.8
Connections8

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of MO ACTIVITIES is 0.3% (very low). The 2024 annual accounts show equity of €2.75M and a net result of €852k. Equity is growing by ~30.9% per year across the filed fiscal years. Its solvency ranks better than 88% of 255 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Signals

3 signals · with evidence
Strong solvency vs sector
Solvency is in the sector's strongest quartile: better than 88% of 255 peers (2024). A comfortable equity buffer.
View the sector comparison
Consistently profitable
Positive net result in the two most recent financial years (2023 and 2024).
View the result trend
Growing equity
Equity grew over 2022-2024. Profits are largely retained rather than distributed.
View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 12 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 22-07-2025, 9 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 4 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 22-07-2025 9 d early 2025-00304152
31-12-2023 31-07-2024 30-09-2024 61 d late 2024-00488710
31-12-2022 31-07-2023 29-08-2023 29 d late 2023-00382832
31-12-2021 31-07-2022 07-09-2022 38 d late 2022-20423329

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.3% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Higher-failure-rate region +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

Turnover€0
EBIT marginNot published (abbreviated filing)
Net result€852k+47.3%
Working capital€2.29M+52.6%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 22-07-2025 with the NBB · fiscal year 2024 · volledig
€0€500k€1.00MOperating result 2021: €715k€715kNet result 2021: €494k€494kRevenue 2022: €0€0Operating result 2022: €724k€724kNet result 2022: €492k€492kRevenue 2023: €0€0Operating result 2023: €750k€750kNet result 2023: €578k€578kRevenue 2024: €0€0Operating result 2024: €1.12M€1.12MNet result 2024: €852k€852k2021202220232024
RevenueOperating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~30.9%/year over 4 fiscal years, indicative, assuming unchanged policy.
€0€2.00M€4.00M€6.00M2025: €3.60M (€3.38M - €3.82M)2026: €4.71M (€4.49M - €4.93M)2027: €6.16M (€5.94M - €6.38M)2021: €1.22M2022: €1.72M2023: €2.09M2024: €2.75M2021202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (full schema)
Metric This company Sector median Position in the sector
Solvency 87.2% 49.4%
better than 88% of 255 sector peers
Net result €852k €50k
better than 95% of 254 sector peers
Equity €2.75M €126k
better than 95% of 255 sector peers
Gross operating margin €1.56M €145k
better than 95% of 250 sector peers
Staff costs €295k €156k
higher than 62% of 114 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P88
2021: P83 · n=1272022: P94 · n=1972023: P91 · n=2252024: P88 · n=2552021 2024
Stable position over 2021-2024 · n=127-255
Net result P95
2021: P95 · n=1272022: P95 · n=1972023: P95 · n=2232024: P95 · n=2542021 2024
Stable position over 2021-2024 · n=127-254
Equity P95
2021: P87 · n=1272022: P94 · n=1972023: P95 · n=2252024: P95 · n=2552021 2024
Stable position over 2021-2024 · n=127-255
Gross operating margin P95
2021: P90 · n=1252022: P93 · n=1942023: P92 · n=2212024: P95 · n=2502021 2024
Stable position over 2021-2024 · n=125-250
Describes the position versus peers, not a forecast.
Revenue
€0
- 21-24
EBITDA
€1.26M
+40.8% 21-24
Net profit
€852k
+47.3% 21-24
Cash flow
€991k
+37.0% 21-24
Total assets
€3.16M
+31.8% 21-24
Equity
€2.75M
+31.5% 21-24
Working capital
€2.29M
+52.6% 21-24
Employees (FTE)
8
+44.4% 21-24
Staff costs
€295k
+24.9% 21-24
Income taxes
€288k
+53.3% 21-24
Dividends
€192k
-4.8% 21-24
Debt
€405k
+33.6% 21-24
Debt ≤ 1y
€405k
+33.5% 21-24
Debt > 1y
€0
-100.0% 21-24
Current ratio
6.66
+11.9% 21-24
Quick ratio
6.66
+11.9% 21-24
Solvency
87.2%
-0.2% 21-24
Debt / equity
0.15
+1.6% 21-24
ROE
30.9%
+11.9% 21-24
ROA
27.0%
+11.7% 21-24
Interest coverage
371.28
+57.8% 21-24
Figures by fiscal year
Fiscal year2024
Depositvolledig
Revenue€0
EBITDA€1.26M
Net profit€852k
Cash flow€991k
Staff costs€295k
Income taxes€288k
Dividends€192k
Total assets€3.16M
Equity€2.75M
Debt€405k
of which ≤ 1y€405k
of which > 1y-
Working capital€2.29M
Employees (FTE)7.8
Ratios (computed)
2024
Current ratio6.66
Quick ratio6.66
Working capital ratio72.6%
Solvency87.2%
Debt / equity0.15
Long-term debt ratio-
Interest coverage371.28
Gross margin-
Net margin-
ROA27.0%
ROE30.9%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€3.16M
Fixed assets 21/28€459k
Intangible fixed assets 21€1k
Tangible fixed assets 22/27€407k
Financial fixed assets 28€51k
Current assets 29/58€2.70M
Amounts receivable within one year 40/41€103k
Investments 50/53€85k
Cash & bank 54/58€1.37M
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€3.16M
Equity 10/15€2.75M
Contributions / capital 10/11€12k
Reserves 13€1.25M
Accumulated profits (losses) 14€1.49M
Amounts payable 17/49€405k
Amounts payable within one year 42/48€405k
Trade debts payable within one year 44€79k
Income statement
Turnover 70€0
Gross operating margin 9900€1.56M
Operating result 9901€1.12M
Financial income 75€22k
Financial charges 65€3k
Result before taxes 9903€1.14M
Income taxes 67/77€288k
Net result for the period 9904€852k
Result to be appropriated 9905€852k
You're seeing the latest fiscal year only. Unlock 3 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
100 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Directors

Directors & mandates

under verification
Directors derived from a single State Gazette act, under verification
All 3 current directors first appear in the same act (25161673). Founders or capital subscribers may have been counted as directors here; the real board composition is being verified.
Current directors & mandates
  • EQIRISLegal entity
    Director· perm. rep.: Bernard Heintz
    State Gazette act 25161673 (23-12-2025)
    Current
    27-11-2025 → present
  • MED.OPHTALegal entity
    Director· perm. rep.: Jean Assaf
    State Gazette act 25161673 (23-12-2025)
    Current
    18-11-2025 → present
  • SignifeyeLegal entity
    Director· perm. rep.: Kathleen Moons
    State Gazette act 25161673 (23-12-2025)
    Current
    18-11-2025 → present
Former directors (1)
  • Jean Assaf
    Director
    State Gazette act 25161673 (23-12-2025)
    Former
    - → 18-11-2025
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary Activiteiten van medisch specialisten(86220)
Legal form Private limited company(610)
Incorporation05-07-2021
StatusActive
Postal code1180

Structure & network

Connections & network

8 connected companies
EQIRIS, Sits on the board EEQIRISMED.OPHTA, Sits on the board MMED.OPHTASignifeye, Sits on the board SSignifeyeBredabaan 552, Shared corporate director B5Bredabaan 552Center for sight - Dr. E. Mertens, Shared corporate director CFCenter forsight - …rtensDR. F. KESTELOOT, Shared corporate director DFDR. F.KESTELOOTDr. M. Dieltiëns, Shared corporate director DMDr. M.DieltiënsOAMM, Shared corporate director OOAMMMO ACTIVITIES MOACTIVITIES0770.711.322
Group structureShared directors
Group structure
EQIRIS
Sits on the board · 6 subsidiaries · 1 location
Control
MED.OPHTA
Sits on the board · 3 subsidiaries · 1 location
Control
Signifeye
Sits on the board · 5 subsidiaries · 1 location
Control
Network connections
Bredabaan 552
Shared corporate director
Center for sight - Dr. E. Mertens
Shared corporate director
DR. F. KESTELOOT
Shared corporate director
Dr. M. Dieltiëns
Shared corporate director
OAMM
Shared corporate director
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.

Ownership & control

3 parties
Control over this companysits on this company's board3
6 subsidiaries · 1 location
5 subsidiaries · 1 location
3 subsidiaries · 1 location
controls
MO ACTIVITIESBE 0770.711.322

Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.

Locations & real estate

Registered office

from the Crossroads Bank
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Papenkasteelstraat 331180 Ukkel

Establishment units

1 location
MO ACTIVITIES
Sint-Huibrechtsstraat 49, 1150 Sint-Pieters-WoluweActiviteiten van medisch specialisten
since 20212.320.417.469
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels2
Ground area2,829 m²
Buildings2
Building footprint1,384 m²
Volume (LiDAR)19,182 m³
Tallest building18.6 m · ±5 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Brussels 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21019A0215/00G014 Brussels 2,109 m² 1 · 1,283 m² 18.6 m · 5 fl.
21614E0176/00L008 Brussels 719 m² 1 · 101 m² 8.7 m · 2 fl.
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

3 acts
All acts · 3 updated 6 months ago
2026
11-02-2026 Articles of association amended Statutes amendment
2025
23-12-2025 3 directors appointed, 1 resigning Director changes
  • Kathleen Moons, Bestuurder
  • Jean Assaf, Bestuurder
  • Bernard Heintz, Bestuurder
  • Jean Assaf, Bestuurder
Summary: v3.2
2021
13-07-2021 Incorporation of a new SRL Incorporation
Summary: oprichting

Analysis

Snowflake analysis

financial profile on 5 axes
Health100Profitability100Solvency100Growth78Stability94
94 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 100
Profitability 100
Solvency 100
Growth 78
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Praktijken van specialisten86220Activiteiten van medisch specialisten86220Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen68201
Primary activity highlighted.
Names & trade names
Legal nameFR MO ACTIVITIES
Registered office
Papenkasteelstraat 33
1180 Ukkel, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.